Botox and Dysport are two of the most popular injectable treatments for reducing wrinkles. Both relax targeted muscles to smooth facial lines and help achieve a more youthful appearance. While they share similarities, key differences between Botox and Dysport can influence which one suits your needs.
Botox vs Dysport: What Are They?
Both Botox and Dysport are derived from botulinum toxin type A, but their formulations differ. Botox, approved by the FDA in 2002, contains onabotulinumtoxinA. Dysport, approved in 2009, uses abobotulinumtoxinA. These differences in formulation affect how each product spreads, how quickly it works, and how long results last.
How Do They Work?
Both Botox and Dysport block nerve signals to muscles, causing them to relax. This reduces the appearance of wrinkles caused by repetitive movements, such as frowning or smiling. Dysport often takes effect faster, with results visible in as little as 24 hours. Botox typically requires 72 hours or more to show visible results. Each treatment works slightly differently, so it’s essential to discuss your goals with an expert.
Dosage and Strength: Botox vs Dysport
Botox and Dysport have different dosing guidelines. For example, 25 units of Dysport may equal 10 units of Botox. However, these products are not interchangeable, and your injector will tailor the dosage to your needs. Trusting a skilled provider ensures accurate and effective results.
How Long Do Results Last?
Both Botox and Dysport offer temporary results, lasting about three to six months. Some studies suggest Dysport may last slightly longer for certain individuals. According to a peer reviewed study on botulinum toxin products, "[G]reater amounts of active neurotoxin are injected with Dysport®, at FDA-approved doses, than with other products. This fact might explain the long duration of action reported across multiple indications, which benefits patients, caregivers, clinicians, and healthcare systems." Factors like muscle activity, dosage, and individual physiology also play a role. Regular treatments can help maintain a smooth, youthful look.
What Can Botox and Dysport Treat?
Both injectables target dynamic wrinkles, including frown lines, forehead wrinkles, and crow’s feet. Botox offers additional FDA-approved treatments, such as for migraines, excessive sweating, and eyelid twitching. Dysport is more often chosen for larger areas, like forehead wrinkles, due to its tendency to spread more easily.
How to Choose Between Botox vs Dysport
Choosing between Botox and Dysport depends on your cosmetic goals and unique needs. Botox may be ideal if you need treatment for medical conditions like migraines or hyperhidrosis. Dysport may appeal if you want quicker results or are treating larger facial areas. Both are safe and effective when administered by a qualified injector.
Safety and Side Effects
Botox and Dysport have similar safety profiles, with most side effects being mild and temporary. Common reactions include redness, swelling, or bruising at the injection site. Rarely, individuals may experience drooping eyelids or difficulty swallowing. Consulting with an experienced provider minimizes risks and ensures the best results.
Why Consult with an Expert?
While Botox and Dysport share many similarities, the right choice depends on your facial structure, aesthetic goals, and medical history. An expert injector can recommend the best product for your needs, whether you’re addressing fine lines, wrinkles, or more complex concerns. Customizing your treatment plan ensures you achieve your desired look.
Which should you try?
Still wondering whether Botox vs Dysport, or a combination of both is best for you? Learn more about our injectables here. Schedule a consultation with Angels Aesthetics today! Text us at 301-254-6696 to create your personalized treatment plan and start your journey toward a refreshed, youthful appearance.
Works Cited:
Field M, Splevins A, Picaut P, et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients [published correction appears in Toxins (Basel). 2019 Feb 13;11(2):E115. doi: 10.3390/toxins11020115]. Toxins (Basel). 2018;10(12):535. Published 2018 Dec 13. doi:10.3390/toxins10120535
Comentarios